Cigna Corporation (NYSE: CI) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ralph Giacobbe -- Senior Vice President of Investor Relations David
Cigna Corporation (CI) Q4 2022 Earnings Call Transcript

Cigna Corporation (NYSE: CI) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ralph Giacobbe -- Senior Vice President of Investor Relations David
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe -- Vice President, Investor Relations Leonard S.
GoHealth Inc (NASDAQ:GOCO) Q3 2022 Earnings Call dated Nov. 10, 2022. Corporate Participants: Brian Farley -- Chief Legal Officer Vijay Kotte -- Chief Executive Officer Jason
BioLife Solutions Inc (NASDAQ:BLFS) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman and Chief
TRxADE Health Inc (NASDAQ:MEDS) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Founder, Chairman and
FibroGen Inc (NASDAQ:FGEN) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Michael Tung -- Investor Relations Enrique Conterno -- Chief Executive Officer Juan Graham -- Chief
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Matthew Murphy -- Investor Relations Manager Christopher Posner -- Chief Executive Officer,
Cigna Corporation (NYSE:CI) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ralph Giacobbe -- Head of IR David Cordani -- Chairman of the Board,
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Atabak Mokari -- CFO Joseph Belanoff -- CEO Sean Maduck -- President of Endocrinology
Amgen Inc (NASDAQ:AMGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Arvind Sood -- Vice President of Investor Relations Bob Bradway -- Chairman &
Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Matt Roache -- Director of Investor Relations Thomas McCourt -- Chief Executive
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ryan Crowe -- Vice President, Investor Relations Leonard Schleifer -- President and
CVS Health Corporation (NYSE:CVS) Q3 2022 Earnings Call dated Nov. 02, 2022. Corporate Participants: Larry McGrath -- Senior Vice President of Business Development and
Merck & Co Inc (NYSE:MRK) Q3 2022 Earnings Call dated Oct. 27, 2022. Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Robert
Agilysys, Inc (NASDAQ:AGYS) Q2 2023 Earnings Call dated Oct. 25, 2022. Corporate Participants: Jessica Hennessy -- Senior Director of Corporate Strategy and Investor Relations